Company Profiles

driven by the PitchBook Platform

Trellis Bioscience

Description

Provider of human antibodies for treating infectious disease. The company engages in the discovery of therapeutic monoclonal antibodies for the treatment of cancer.

1998

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$3.3M

Latest Deal Amount

$48.2M

Total Amount Raised

Description

Provider of human antibodies for treating infectious disease. The company engages in the discovery of therapeutic monoclonal antibodies for the treatment of cancer.

Website:

www.trellisbio.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals
Drug Discovery

Primary Office

1505-B O'Brien Drive Menlo Park, CA 94025United States +1 (650) 838-1400
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Trellis Bioscience's full profile, request a free trial.

    Trellis Bioscience Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Trellis Bioscience Investors (8)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Easton Capital Investment GroupVenture CapitalMinority000 0000000 0000
    Forward VenturesVenture CapitalMinority000 0000000 0000
    InvestBio VenturesVenture CapitalMinority000 0000000 0000
    Morgenthaler VenturesVenture CapitalMinority000 0000000 0000
    National Institute Of Allergy and Infectious Diseases Extramural ActivitesGovernment000 0000000 0000
    Easton Capital Investment Group Venture Capital
    Forward Ventures Venture Capital
    InvestBio Ventures Venture Capital
    Morgenthaler Ventures Venture Capital
    National Institute Of Allergy and Infectious Diseases Extramural Activites Government

    Trellis Bioscience Executive Team (10)

    NameTitleBoard
    Seat
    Contact
    Info
    Stefan Ryser Ph.DPresident, Board Member & Chief Executive Officer
    Stote EllsworthCo-Chief Technology Officer & Board Member
    Bruce Keyt Ph.DCo-Chief Technology Officer & Chief Scientific Officer
    Reyna Simon Ph.DDirector, Project and Alliance Management
    Bill UsingerHead, Research & Development & Vice President
    Stefan Ryser Ph.D President, Board Member & Chief Executive Officer
    Stote Ellsworth Co-Chief Technology Officer & Board Member
    Bruce Keyt Ph.D Co-Chief Technology Officer & Chief Scientific Officer
    Reyna Simon Ph.D Director, Project and Alliance Management
    Bill Usinger Head, Research & Development & Vice President

    Trellis Bioscience Board Members (7)

    NameRepresentingRoleSinceContact
    Info
    Jack AnthonySelfBoard Member000 0000
    John Friedman JDEaston Capital Investment GroupFounding Partner & Managing Partner000 0000
    John Saxe JDSelfChairman000 0000
    Markus Goebel Ph.DNovartis Venture FundCo-Managing Director000 0000
    Shirley ClaytonSelfBoard Member000 0000
    Jack Anthony Board Member Self
    John Friedman JD Founding Partner & Managing Partner Easton Capital Investment Group
    John Saxe JD Chairman Self
    Markus Goebel Ph.D Co-Managing Director Novartis Venture Fund
    Shirley Clayton Board Member Self
    Request full access to PitchBook